CanSino Biologics (6185) Announces Board of Supervisors Cancellation, Governance Updates, and Director Nominations

Bulletin Express

Nov 11

CanSino Biologics Inc. (6185) informed shareholders of its plan to hold the 2025 second extraordinary general meeting on November 27, 2025, in Tianjin, where multiple proposals will be reviewed and voted upon.

Key motions include a proposal to cancel the Board of Supervisors and make corresponding amendments to the Company’s articles of association and other procedural rules. In addition, amendments to several corporate governance rules are tabled, covering funds management and related party transactions, among others.

The meeting will also consider a plan to utilize reserves to offset historical losses. Another highlight is the proposed appointment of two independent non-executive directors, who are nominated pending shareholder approval at the upcoming meeting.

The Company reminds eligible shareholders to review the details of these proposals and attend or appoint proxies in accordance with relevant instructions by November 26, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1175307915"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175307915\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175307915?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175307915","market":"hk","top_or_hot":-1,"title":"CanSino Biologics (6185) Announces Board of Supervisors Cancellation, Governance Updates, and Director Nominations","media":"Bulletin Express","content":"<p>CanSino Biologics Inc. (6185) informed shareholders of its plan to hold the 2025 second extraordinary general meeting on November 27, 2025, in Tianjin, where multiple proposals will be reviewed and voted upon.</p>\n<p>Key motions include a proposal to cancel the Board of Supervisors and make corresponding amendments to the Company’s articles of association and other procedural rules. In addition, amendments to several corporate governance rules are tabled, covering funds management and related party transactions, among others.</p>\n<p>The meeting will also consider a plan to utilize reserves to offset historical losses. Another highlight is the proposed appointment of two independent non-executive directors, who are nominated pending shareholder approval at the upcoming meeting.</p>\n<p>The Company reminds eligible shareholders to review the details of these proposals and attend or appoint proxies in accordance with relevant instructions by November 26, 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CanSino Biologics (6185) Announces Board of Supervisors Cancellation, Governance Updates, and Director Nominations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanSino Biologics (6185) Announces Board of Supervisors Cancellation, Governance Updates, and Director Nominations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CanSino Biologics Inc. (6185) informed shareholders of its plan to hold the 2025 second extraordinary general meeting on November 27, 2025, in Tianjin, where multiple proposals will be reviewed and voted upon.</p>\n<p>Key motions include a proposal to cancel the Board of Supervisors and make corresponding amendments to the Company’s articles of association and other procedural rules. In addition, amendments to several corporate governance rules are tabled, covering funds management and related party transactions, among others.</p>\n<p>The meeting will also consider a plan to utilize reserves to offset historical losses. Another highlight is the proposed appointment of two independent non-executive directors, who are nominated pending shareholder approval at the upcoming meeting.</p>\n<p>The Company reminds eligible shareholders to review the details of these proposals and attend or appoint proxies in accordance with relevant instructions by November 26, 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1175307915","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175307915","pubTimestamp":1762850883,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CanSino Biologics Inc. (6185) informed shareholders of its plan to hold the 2025 second extraordinary general meeting on November 27, 2025, in Tianjin, where multiple proposals will be reviewed and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物"},"translate_title":"康希诺生物(6185)公布监事会注销、管治更新、董事提名","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"CanSino Biologics Inc. (6185) informed shareholders of its plan to hold the 2025 second extraordinary general meeting on November 27, 2025, in Tianjin, where multiple proposals will be reviewed and voted upon.\nKey motions include a proposal to cancel the Board of Supervisors and make corresponding amendments to the Company’s articles of association and other procedural rules. In addition, amendments to several corporate governance rules are tabled, covering funds management and related party transactions, among others.\nThe meeting will also consider a plan to utilize reserves to offset historical losses. Another highlight is the proposed appointment of two independent non-executive directors, who are nominated pending shareholder approval at the upcoming meeting.\nThe Company reminds eligible shareholders to review the details of these proposals and attend or appoint proxies in accordance with relevant instructions by November 26, 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}